1-(4-羟基苯基)-3-甲基丁烷-1-酮 | 34887-83-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-(4-羟基苯基)-3-甲基丁烷-1-酮
• 英文名称: 1-(4-hydroxyphenyl)-3-methylbutan-1-one
• 英文别名: 1-(p-hydroxyphenyl)-3-methyl-1-butanone；1-(4-hydroxy-phenyl)-3-methyl-butan-1-one；1-(4-Hydroxy-phenyl)-3-methyl-butan-1-on；isopropyl-4-hydroxy-acetophenone；4-hydroxyisovalerophenone；4-Hydroxyphenylisobutylketon
• CAS: 34887-83-7
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: YFUVTWCBNMKSRV-UHFFFAOYSA-N

物化性质

• 熔点：
  95-96 °C
• 沸点：
  145-147 °C(Press: 0.1 Torr)
• 密度：
  1.052±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(4-羟基苯基)-3-甲基丁烷-1-酮 在 palladium on activated charcoal 高氯酸 、 氢气 作用下， 以 乙醇 为溶剂， 25.0 ℃ 、101.33 kPa 条件下， 生成 4-异戊基苯酚
  参考文献：
  名称：

  Casnati,G. et al., Gazzetta Chimica Italiana, 1964, vol. 94, p. 1221 - 1247

  摘要：

  DOI：
• 作为产物：
  描述：

  1-(4-甲氧基苯基)-3-甲基-1-丁酮 在 吡啶盐酸盐 作用下， 生成 1-(4-羟基苯基)-3-甲基丁烷-1-酮
  参考文献：
  名称：

  Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs

  摘要：

  A series of 3-alkyl, 3-cycloalkyl, and 3-heteroaryl dihydrobenzoxathim analogs 1 were prepared and evaluated for estrogen/anti-estrogen activity in both in vitro and in vivo models. In general, the compounds were found to exhibit a high degree of selectivity for ERalpha over ERbeta, but were less potent than the original lead compound la in the inhibition of estradiol-driven uterine proliferation. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.02.084

文献信息

• Pd-Catalyzed Carbonylative Cross-Coupling Reactions by Triorganoindiums:  Highly Efficient Transfer of Organic Groups Attached to Indium under Atmospheric Pressure
  作者：Phil Ho Lee、Sung Wook Lee、Kooyeon Lee

  DOI：10.1021/ol034167j

  日期：2003.4.1

  [reaction: see text] A highly atom-efficient synthetic method of unsymmetrical ketones was developed by using trialkyl- and triarylindiums, which could be employed as effective cross-coupling partners in Pd-catalyzed carbonylative cross-coupling reactions with a variety of organic electrophiles. The present method produced unsymmetrical ketones and 1,4-diacylbenzenes in good yields with highly efficient

  [反应：参见文本]通过使用三烷基和三芳基鎓化合物开发了一种高度原子效率的不对称酮合成方法，该方法可作为Pd催化的羰基交叉偶联反应与多种有机亲电试剂的有效交叉偶联伙伴。 。本方法以高收率生产不对称的酮和1,4-二酰基苯，并且在66°C的THF中在CO气体的大气压下，高效地转移了几乎所有附着在铟上的有机基团。
• A Novel Parkinson’s Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway
  作者：Ya-Dan Wang、Xiu-Qi Bao、Song Xu、Wen-Wen Yu、Sheng-Nan Cao、Jin-Ping Hu、Yan Li、Xiao-Liang Wang、Dan Zhang、Shi-Shan Yu

  DOI：10.1021/acs.jmedchem.6b00976

  日期：2016.10.13

  mice at a median lethal dose (LD50) >5000 mg/kg. Its in vivo efficacy was demonstrated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- and MPTP/probenecid (prob)-induced subacute and chronic PD models, respectively, and α-synuclein transgenic mice. Mechanistic studies revealed neuroinflammation inhibition by targeting Src/phosphatase and tensin homologue deleted on chromosome 10 (PTEN)/Akt signaling

  帕金森氏病（PD）是一种与年龄有关的神经退行性疾病，目前有许多药物治疗方法，但大多数都会引起严重的副作用。因此，迫切需要能够阻止疾病进展并允许长期给药的新型治疗策略。神经炎症在PD的发病机理中起关键作用。在这里，我们报告发现和优化间苯三酚衍生物，一类新型的抗神经炎化合物。对命中化合物3-甲基-1-（2,4,6-三羟基苯基）丁-1-的结构修饰产生了43种衍生物，包括临床前候选药物（化合物21），具有良好的体外抗神经炎作用，具有良好的体外抗炎性。在中等致死剂量下小鼠血脑屏障穿透力和理想的安全裕度（LD 50）> 5000 mg / kg。分别在1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）-和MPTP / probenecid（prob）诱导的亚急性和慢性PD模型以及α-突触核蛋白转基因模型中证明了其体内功效老鼠。机理研究表明，通过靶向10号染色体（PTEN）/ Akt信号缺失的Src
• Estrogen receptor modulators
  申请人：——

  公开号：US20030225132A1

  公开（公告）日：2003-12-04

  The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including: bone loss, bone fractures, osteoporosis, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders, restenosis, gynecomastia, vascular smooth muscle cell proliferation, obesity, incontinence, and cancer, in particular of the breast, uterus and prostate.

  本发明涉及化合物及其衍生物，它们的合成以及它们作为雌激素受体调节剂的用途。本发明的化合物是雌激素受体的配体，因此可能对治疗或预防与雌激素功能相关的多种疾病条件有用，包括：骨质疏松、骨折、骨质疏松症、软骨退化、子宫内膜异位症、子宫肌瘤病、潮热、低密度脂蛋白胆固醇水平升高、心血管疾病、认知功能障碍、脑退行性疾病、再狭窄、男性乳房增大、血管平滑肌细胞增殖、肥胖、尿失禁和癌症，尤其是乳腺、子宫和前列腺癌。
• An Improved Synthesis of Hydroxy Aryl Ketones by Fries Rearrangement with Methanesulfonic Acid/Methanesulfonic Anhydride
  作者：Ingyu Jeon、Ian Mangion

  DOI：10.1055/s-0032-1316568

  日期：2012.8

  Methanesulfonic acid treated with methanesulfonic anhydride effectively mediates the Fries rearrangement of aryl esters to give hydroxy aryl ketones with high yields.

  用甲磺酸酐处理的甲磺酸有效地介导芳基酯的弗里斯重排，以高产率得到羟基芳基酮。
• synthesis and Aldose Reductase Inhibitory Activities of Benzyl 2-Oxazolecarbamate Analogues.
  作者：Naoko MIYAHARA、Yoko KASUGAI、Yoshiro OHMOMO、Chiaki TANAKA、Tsuyoshi TANIMOTO

  DOI：10.1248/cpb.40.245

  日期：——

  Various analogues of benzyl 5-phenyl-2-oxazolecarbamate (1a) were synthesized, and the structure-activity relationship of these analogues as aldose reductase inhibitor was studied. The carbamate group was necessary for the inhibitory activity. The introduction of an alkyl group at the C-4 position of 1a enhanced the inhibitory activity, however, the N-carboxymethyl group on the carbamate moiety counteracted to a hydrophobic interaction between the alkyl group at the C-4 position and the enzyme molecule.

  合成了多种苄基5-苯基-2-噁唑卡巴胺（1a）的类似物，并研究了这些类似物作为醛糖还原酶抑制剂的结构-活性关系。卡巴胺基团对于抑制活性是必需的。在1a的C-4位引入烷基基团增强了抑制活性，然而，卡巴胺部分的N-羧甲基基团抵消了C-4位烷基与酶分子之间的疏水相互作用。